| |
| |
|
| Insider
Information: |
Sing George L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,472 |
|
|
Indirect Shares
|
2,150 |
|
|
| Direct
Value |
$26,752,234 |
|
|
|
Indirect Value
|
$2,093,670 |
|
|
| Total
Shares |
29,622 |
|
|
| Total
Value |
$28,845,904 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
34
|
|
Stock
price went up :
|
0
|
17
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -3.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-05-03 |
27,472 |
2024-05-03 |
2,150 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-26 |
4 |
S |
$672.00 |
$100,800 |
I/I |
(150) |
1,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-11-16 |
4 |
S |
$650.00 |
$487,500 |
I/I |
(750) |
1,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-30 |
4 |
S |
$670.00 |
$369,100 |
I/I |
(550) |
1,750 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-16 |
4 |
S |
$627.50 |
$627,500 |
I/I |
(1,000) |
2,050 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-11-13 |
4 |
B |
$18.68 |
$46,728 |
I/I |
2,500 |
2,500 |
2.1 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-11 |
4 |
S |
$620.00 |
$186,000 |
I/I |
(300) |
3,050 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-06 |
4 |
S |
$612.42 |
$214,347 |
I/I |
(350) |
3,350 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-25 |
4 |
S |
$612.00 |
$612,000 |
I/I |
(1,000) |
3,700 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-11-18 |
4 |
S |
$580.00 |
$290,000 |
I/I |
(500) |
4,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-07-07 |
4 |
AS |
$650.00 |
$1,950,474 |
I/I |
(3,000) |
4,700 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-05-18 |
4 |
B |
$28.64 |
$71,600 |
I/I |
2,500 |
5,000 |
2.1 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-29 |
4 |
AS |
$606.80 |
$1,826,721 |
I/I |
(3,000) |
6,200 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-29 |
4 |
S |
$595.00 |
$596,510 |
I/I |
(1,000) |
7,700 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-28 |
4 |
S |
$578.00 |
$579,000 |
I/I |
(1,000) |
8,200 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-11 |
4 |
S |
$575.00 |
$488,750 |
I/I |
(850) |
8,700 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-02-26 |
4 |
S |
$450.00 |
$1,086,800 |
I/I |
(2,400) |
9,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-12-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-02-28 |
4 |
S |
$614.00 |
$1,231,000 |
D/D |
(2,000) |
26,049 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
26,214 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
26,349 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-08 |
4 |
S |
$945.00 |
$472,500 |
D/D |
(500) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-09 |
4 |
S |
$955.00 |
$477,500 |
D/D |
(500) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-22 |
4 |
S |
$960.00 |
$2,895,000 |
D/D |
(3,000) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-23 |
4 |
S |
$985.00 |
$492,500 |
D/D |
(500) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-26 |
4 |
S |
$990.00 |
$992,500 |
D/D |
(1,000) |
26,349 |
0 |
% |
|
100 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
